Your browser doesn't support javascript.
loading
Ribosomal mutations promote the evolution of antibiotic resistance in a multidrug environment.
Gomez, James E; Kaufmann-Malaga, Benjamin B; Wivagg, Carl N; Kim, Peter B; Silvis, Melanie R; Renedo, Nikolai; Ioerger, Thomas R; Ahmad, Rushdy; Livny, Jonathan; Fishbein, Skye; Sacchettini, James C; Carr, Steven A; Hung, Deborah T.
Afiliação
  • Gomez JE; The Broad Institute of MIT and Harvard, Cambridge, United States.
  • Kaufmann-Malaga BB; The Broad Institute of MIT and Harvard, Cambridge, United States.
  • Wivagg CN; Department of Molecular Biology and Center for Computational and Integrative Biology, Massachusetts General Hospital, Boston, United States.
  • Kim PB; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, United States.
  • Silvis MR; The Broad Institute of MIT and Harvard, Cambridge, United States.
  • Renedo N; Department of Molecular Biology and Center for Computational and Integrative Biology, Massachusetts General Hospital, Boston, United States.
  • Ioerger TR; The Broad Institute of MIT and Harvard, Cambridge, United States.
  • Ahmad R; The Broad Institute of MIT and Harvard, Cambridge, United States.
  • Livny J; The Broad Institute of MIT and Harvard, Cambridge, United States.
  • Fishbein S; Department of Computer Science, Texas A&M University, College Station, United States.
  • Sacchettini JC; The Broad Institute of MIT and Harvard, Cambridge, United States.
  • Carr SA; The Broad Institute of MIT and Harvard, Cambridge, United States.
  • Hung DT; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, United States.
Elife ; 62017 02 21.
Article em En | MEDLINE | ID: mdl-28220755

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ribossomos / Mycobacterium smegmatis / Farmacorresistência Bacteriana / Mutação Tipo de estudo: Prognostic_studies Idioma: En Revista: Elife Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ribossomos / Mycobacterium smegmatis / Farmacorresistência Bacteriana / Mutação Tipo de estudo: Prognostic_studies Idioma: En Revista: Elife Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos